|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,163.00 GBX | +1.84% |
|
+1.57% | +13.57% |
| 07-08 | Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs, Effective July 7, 2025 | CI |
| 06-30 | Indivior PLC(NasdaqGS:INDV) added to Russell 3000 Value Index | CI |
| Capitalization | 1.92B 1.64B 1.53B 1.42B 2.63B 165B 2.93B 18.36B 7.02B 77.27B 7.21B 7.06B 283B | P/E ratio 2025 * |
13.5x | P/E ratio 2026 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise value | 1.85B 1.59B 1.48B 1.37B 2.54B 159B 2.82B 17.69B 6.77B 74.48B 6.95B 6.81B 273B | EV / Sales 2025 * |
1.82x | EV / Sales 2026 * | 1.66x |
| Free-Float |
96.11% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Indivior PLC
More recommendations
More press releases
More news
| 1 day | +1.80% | ||
| 1 week | +1.57% | ||
| Current month | +7.29% | ||
| 1 month | +11.83% | ||
| 3 months | +64.96% | ||
| 6 months | +27.38% | ||
| Current year | +13.57% |
| 1 week | 1,084 |  | 1,179 |
| 1 month | 975.5 | | 1,179 |
| Current year | 598.5 | | 1,179 |
| 1 year | 554.5 | | 1,179 |
| 3 years | 554.5 | | 2,020 |
| 5 years | 335 | | 2,020 |
| 10 years | 104.9 | | 2,523 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Ciaffoni
CEO | Chief Executive Officer | 54 | - |
Ryan Preblick
DFI | Director of Finance/CFO | 49 | 28/06/2020 |
Vishal Kalia
COO | Chief Operating Officer | 44 | 31/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Juliet Thompson
BRD | Director/Board Member | 58 | 23/03/2021 |
Mark Stejbach
BRD | Director/Board Member | 62 | 23/03/2021 |
Barbara Ryan
BRD | Director/Board Member | 65 | 31/05/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.84% | +1.57% | +50.26% | -21.95% | 1.92B | ||
| -2.84% | +0.37% | -27.68% | -35.87% | 57.35B | ||
| -0.20% | -1.51% | -20.34% | -23.14% | 8.81B | ||
| +0.51% | +6.42% | +9.80% | +22.35% | 7.04B | ||
| -0.27% | +4.60% | +17.39% | +115.09% | 6.08B | ||
| -2.75% | +4.60% | +15.18% | +22.25% | 5.6B | ||
| +0.71% | +0.26% | +78.53% | +7.91% | 3.39B | ||
| +1.28% | +6.74% | +16.85% | +16.60% | 2.07B | ||
| +0.27% | +0.55% | -9.65% | +16.44% | 2.06B | ||
| +0.53% | +9.61% | +93.73% | +40.12% | 1.92B | ||
| Average | -0.10% | +3.22% | +22.41% | +15.98% | 9.62B | |
| Weighted average by Cap. | -1.75% | +2.04% | -9.86% | -11.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.02B 873M 813M 756M 1.4B 87.59B 1.55B 9.74B 3.72B 41.01B 3.83B 3.75B 150B | 1.06B 907M 845M 786M 1.45B 91.05B 1.61B 10.13B 3.87B 42.63B 3.98B 3.9B 156B |
| Net income | 145M 124M 116M 108M 199M 12.45B 221M 1.39B 530M 5.83B 544M 533M 21.39B | 170M 145M 136M 126M 233M 14.6B 259M 1.62B 621M 6.83B 638M 625M 25.07B |
| Net Debt | -69.36M -59.31M -55.25M -51.38M -94.94M -5.95B -106M -662M -253M -2.79B -260M -255M -10.22B | -164M -140M -131M -122M -225M -14.08B -250M -1.57B -599M -6.59B -615M -603M -24.18B |
More financial data
* Estimated data
Employees
1,041
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/25 | 1,161.00 p | +1.66% | 71,825 |
| 11/07/25 | 1,142.00 p | +0.97% | 147,134 |
| 10/07/25 | 1,131.00 p | +2.26% | 123,263 |
| 09/07/25 | 1,106.00 p | -1.95% | 156,107 |
| 08/07/25 | 1,128.00 p | -1.48% | 194,357 |
Delayed Quote London S.E., July 14, 2025 at 04:12 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.42USD
Average target price
14.58USD
Spread / Average Target
-5.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition